Finance

Lists
31R:FRA
Revive Therapeutics Ltd
0,010 €
0,00%
(0,00) 1D
9 ოქტ, 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 31R...
Open
0,01 €
High
0,01 €
Low
0,01 €
Mkt. cap
10,49 მლნ.
Avg. vol.
2,94 ათ.
Volume
0,00
52-wk high
0,06 €
52-wk low
0,00 €
Open
0,01 €
High
0,01 €
Low
0,01 €
Mkt. cap
10,49 მლნ.
Avg. vol.
2,94 ათ.
Volume
0,00
52-wk high
0,06 €
52-wk low
0,00 €
News stories
From web sources and news partners
About Revive Therapeutics Ltd
CEO-
Employees-
Founded2012
Headquartersტორონტო, ონტარიო, კანადა
SectorPharmaceutical industry
Websiterevivethera.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
ივნ. 2025
სექ. 2025
დეკ. 2025
მარ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
336,32 ათ.
200,14 ათ.
283,25 ათ.
242,05 ათ.
Operating expense
336,39 ათ.
220,13 ათ.
283,30 ათ.
463,87 ათ.
Total operating expenses
336,39 ათ.
220,13 ათ.
283,30 ათ.
463,87 ათ.
Operating income
-336,39 ათ.
-220,13 ათ.
-283,30 ათ.
-463,87 ათ.
Other non operating income
73,85 ათ.
-
-
-
EBT including unusual items
-9,60 მლნ.
-281,75 ათ.
-238,72 ათ.
-506,50 ათ.
EBT excluding unusual items
-143,94 ათ.
-281,75 ათ.
-234,70 ათ.
-506,50 ათ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9,60 მლნ.
-281,75 ათ.
-238,72 ათ.
-506,50 ათ.
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
277,00
-
-
Interest expense
-
-
-
-
Net interest expenses
-
277,00
-
-
Depreciation and amortization charges
62,00
46,00
48,00
47,00
EBITDA
-336,32 ათ.
-220,08 ათ.
-283,25 ათ.
-463,82 ათ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები